Patient characteristic | Odds ratio for 28-day ACM (95% CI) |
---|---|
Baseline bacteremia with any pathogen (vs no bacteremia)* | 2.7 (1.1, 7.1) |
Concomitant vasopressor use (vs no vasopressor use)‡ | 5.4 (2.6, 11.0) |
Meropenem treatment (vs ceftolozane/tazobactam treatment)§ | 2.3 (1.2, 4.5) |